Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks with high potential. In a report released on October 3, Jason ...

BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement

HOUSTON, TX and SUNSHINE COAST, QUEENSLAND / ACCESS Newswire / October 6, 2025 / BrYet US, Inc. (“BrYet”), a biotechnology innovator developing a drug with the potential to be a first-in-class ...
FMIBlog

Cancer Biological Therapy Market to Reach USD 260.2 Billion by 2035, Driven by Innovation in Precision Oncology and Expanding Global Access

The global Cancer Biological Therapy Market is entering a transformative decade, fueled by breakthroughs in precision ...